Aigen Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-34,284
| Closed | -$2.38M | – | 989 |
|
|
2025
Q1 | $2.38M | Buy |
34,284
+25,769
| +303% | +$1.79M | 0.38% | 58 |
|
|
2024
Q4 | $732K | Buy |
8,515
+6,023
| +242% | +$518K | 0.13% | 233 |
|
|
2024
Q3 | $297K | Buy |
+2,492
| New | +$297K | 0.06% | 476 |
|
|
2024
Q2 | – | Sell |
-6,979
| Closed | -$896K | – | 949 |
|
|
2024
Q1 | $896K | Sell |
6,979
-182
| -3% | -$23.4K | 0.2% | 160 |
|
|
2023
Q4 | $741K | Buy |
+7,161
| New | +$741K | 0.13% | 223 |
|
|
2023
Q3 | – | Sell |
-17,904
| Closed | -$1.45M | – | 1001 |
|
|
2023
Q2 | $1.45M | Buy |
+17,904
| New | +$1.45M | 0.21% | 133 |
|
|
2022
Q3 | – | Sell |
-9,846
| Closed | -$549K | – | 700 |
|
|
2022
Q2 | $549K | Buy |
+9,846
| New | +$549K | 0.09% | 287 |
|
|
2022
Q1 | – | Sell |
-20,154
| Closed | -$1.08M | – | 915 |
|
|
2021
Q4 | $1.08M | Buy |
20,154
+15,596
| +342% | +$836K | 0.07% | 392 |
|
|
2021
Q3 | $219K | Buy |
+4,558
| New | +$219K | 0.04% | 403 |
|